Power Law company profile

GRAIL

Biotech & Life Sciences · Menlo Park, United States · Founded 2016 Unicorn

Developing blood tests for early cancer detection high-intensity sequencing, population-scale clinical trials, and state of the art Computer Science and Data Science

Valuation

$8.00B

Market cap · 2026

Revenue

$147M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

19 investors on GRAIL's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

SV Angel

Series A 6 investors entered at this stage

Sutter Hill Ventures

Illumina

Bezos Expeditions

ARCH Venture Partners

Bill Gates

Series B+ 12 investors entered at this stage

Genuity Science

Johnson & Johnson

China Merchant Securities International

Blue Pool Capital

CRF Investment

Ally Bridge Group

6 Dimensions Capital

Sequoia

CPP Investments

Hillhouse Capital

HuangPu River Capital

Industrial and Commercial Bank of China

GRAIL mafia

Startups founded by GRAIL alumni

Former GRAIL employees who went on to start their own companies. Sorted by Dealroom signal score.

CellanomeEst. 2020

MRMostafa RonaghiUnited States

Signal score94

Beacons AIEst. 2019

Jesse ZhangUnited States

Signal score91

Xaira TherapeuticsEst. 2023

Vik BajajUnited States

Signal score91

Curve BiosciencesEst. 2021

Nathan HunkapillerUnited States

Signal score81

AdelaEst. 2020

AHAnne-Renee HartmanCanada

Signal score77

Altos LabsEst. 2021

Richard KlausnerUnited States

Signal score70

Moonwalk BiosciencesEst. 2022

AJArash JamshidiUnited States

Signal score64

MirvieEst. 2019

Maneesh JainUnited States

Signal score63

ArsenalBioEst. 2019

KDKen DrazanUnited States

Signal score63

BetterOmicsEst. 2020

Angela LaiUnited States

Signal score59

Aria NetworksEst. 2025

Subhachandra ChandraUnited States

Signal score57

Human Native AIEst. 2024

Jack GalileeUnited Kingdom

Signal score51

Book a demo to explore the full alumni network →

Global footprint

Where GRAIL has talent and traffic

AI talent share

3.8% of workforce is AI talent
(41 of 1,093 staff)

Core AI141.28%

Other AI272.47%

Non-AI workforce1,05296.25%

Workforce by country

6 countries with
team presence

🇺🇸 United States94.7%

🇬🇧 United Kingdom4.8%

🇸🇪 Sweden0.1%

🇭🇰 Hong Kong0.1%

🇰🇷 South Korea0.1%

Top 5 of 6 shown

Web traffic by country

91K monthly visits
across markets

🇺🇸 United States53.4%

🇮🇳 India5.4%

🇬🇧 United Kingdom4.4%

🇨🇦 Canada4.3%

🏳️ Korea3.8%

Top 5 markets shown

Patent intelligence

$85M patent portfolio · 186 active families

Estimated portfolio value

$85M

1.1% of market cap · 32.2× smaller than top peer Illumina ($2.7B)

186 active patent families

Where GRAIL innovates BioinformaticsComputational biologyCellMolecular biologyMethylation

Where GRAIL concentrates vs peers

Each axis is a top-10 topic across GRAIL and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about GRAIL

An AI-synthesized read of the highest-engagement posts about GRAIL on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See GRAIL on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles